“Treatment or Psoriasis with Calcipotriene and Betamethasone Dipropionate (CAL/BDP) Cream Showed Significantly Higher Proportion of Patients with an Absolute mPASI≤2 Compared to CAL/BDP Gel/Topical Suspension in a Post-Hoc Aanalysis of Two Phase 3 Studies” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s233. doi:10.25251/skin.7.supp.233.